Figure 3.
Lipidomics. Multivariate analysis using principal component analysis and OPLS‐DA for HCV‐resistant cases (EU, n = 38) compared with HCV‐susceptible (HCV antibody‐positive, n = 295), including chronic HCV patients genotypes 1 or 3 (HCV RNA‐positive, n = 159), SVRs (n = 100), and SRs (n = 36). Summary of data presented as poster 15 at the BASL Annual Meeting 2016.10